Subacute sclerosing panencephalitis: Disease profile in early childhood
- PMID: 40107908
- DOI: 10.1016/j.arcped.2024.11.010
Subacute sclerosing panencephalitis: Disease profile in early childhood
Abstract
Subacute sclerosing panencephalitis (SSPE), a progressive inflammatory neurodegenerative disease of the central nervous system caused by the measles virus, is experiencing a significant resurgence following recent measles epidemics. This study aimed to investigate the pathology of SSPE in early childhood and determine its clinical, electrophysiological, and radiological characteristics.
Materials and methods: This retrospective, descriptive study was conducted at the Pediatric Department of Nafissa Hamoud University Hospital in Algiers. The study included children aged 2-6 years who were hospitalized for subacute neurological disorders. Data collection spanned a 3-year period from January 1, 2020, to December 31, 2022.
Results and discussion: A total of 47 patients were examined, comprising 37 boys and 10 girls. The average age was 45.9 months (range: 24-72 months). Notably, 41 (87 %) of the patients had not received measles vaccination, and 37 (80 %) had contracted the measles virus, with 31 cases (83.8 %) occurring in children under 1 year of age. SSPE manifested approximately 3 years after infection (range: 1-5 years). Clinical events primarily included myoclonic seizures (26 cases), tonic-clonic seizures (6 cases), atonic seizures (6 cases), and focal seizures (3 cases); movement disorders were observed in 25 patients, and cognitive decline in 28 patients. Encephalitis manifestations, such as alterations in consciousness or behavior and psychiatric symptoms, were frequently observed. Electroencephalograms (EEG) revealed characteristic periodic complexes in only 22 patients. Magnetic resonance imaging (MRI) scans were normal in 24 patients but showed characteristic anomalies in 21 patients, primarily consisting of white matter hyperintensity and cortico-subcortical atrophy.
Conclusion: SSPE is not rare in early childhood. The latency period between virus infection and disease onset can be very short. Clinical, electroencephalographic, and radiological signs of the disease in young children may be atypical. Genetic studies are necessary to establish a genetic predisposition to the disease. Measles vaccination remains the most effective preventive measure against SSPE.
Keywords: Encephalitis; Measles; Myoclonus; Periodic; Vaccination.
Copyright © 2025 Société française de pédiatrie. Published by Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
A recent surge of fulminant and early onset subacute sclerosing panencephalitis (SSPE) in the United Kingdom: An emergence in a time of measles.Eur J Paediatr Neurol. 2021 Sep;34:43-49. doi: 10.1016/j.ejpn.2021.07.006. Epub 2021 Jul 16. Eur J Paediatr Neurol. 2021. PMID: 34388650
-
Association Between Clinical Severity, Neuroimaging, and Electroencephalographic Findings in Children with Subacute Sclerosing Panencephalitis.J Child Neurol. 2024 Aug;39(9-10):301-309. doi: 10.1177/08830738241272074. Epub 2024 Aug 23. J Child Neurol. 2024. PMID: 39175398
-
Epilepsy in children with subacute sclerosing panencephalitis.Srp Arh Celok Lek. 2013 Jul-Aug;141(7-8):434-40. doi: 10.2298/sarh1308434j. Srp Arh Celok Lek. 2013. PMID: 24073547
-
Subacute sclerosing panencephalitis.Rev Med Virol. 2019 Sep;29(5):e2058. doi: 10.1002/rmv.2058. Epub 2019 Jun 24. Rev Med Virol. 2019. PMID: 31237061 Review.
-
Subacute sclerosing panencephalitis: an update.Dev Med Child Neurol. 2010 Oct;52(10):901-7. doi: 10.1111/j.1469-8749.2010.03717.x. Epub 2010 Jun 15. Dev Med Child Neurol. 2010. PMID: 20561004 Review.
MeSH terms
LinkOut - more resources
Full Text Sources